CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons-Reference-Cited by-同舟云学术

CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons

Published:2017-10 Issue: Volume:24 Page:44-50
ISSN:1873-5061
Container-title:Stem Cell Research
language:en
Short-container-title:Stem Cell Research

Author:

Qing Xiaobing,Walter Jonas,Jarazo Javier,Arias-Fuenzalida Jonathan,Hillje Anna-Lena,Schwamborn Jens C.

Funder

LCSB

Fonds National de la Recherche

European Union

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference38 articles.

1. LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease;Alegre-Abarrategui;Neuropathol. Appl. Neurobiol.,2008

2. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease;Anderson;J. Biol. Chem.,2006

3. Genetic studies in Parkinson's disease;Barbeau;Adv. Neurol.,1984

4. The genetic epidemiology of neurodegenerative disease;Bertram;J. Clin. Invest.,2005

5. Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2;Deng;Nat. Chem. Biol.,2011

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders;Current Gene Therapy;2025-02

2. Application and perspective of CRISPR/Cas9 genome editing technology in human diseases modeling and gene therapy;Frontiers in Genetics;2024-04-11

3. Micro-and mesoscale aspects of neurodegeneration in engineered human neural networks carrying the LRRK2 G2019S mutation;Frontiers in Cellular Neuroscience;2024-04-05

4. Induced-pluripotent stem cells and neuroproteomics as tools for studying neurodegeneration;Biochemical Society Transactions;2024-01-30

5. Exploring Parkinson-associated kinases for CRISPR/Cas9-based gene editing: beyond alpha-synuclein;Ageing Research Reviews;2023-12